This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Udalova, I. A.
Right arrow Articles by Kwiatkowski, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Udalova, I. A.
Right arrow Articles by Kwiatkowski, D.

 Previous Article  |  Next Article 

Infection and Immunity, September 2000, p. 5447-5449, Vol. 68, No. 9
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Direct Evidence for Involvement of NF-kappa B in Transcriptional Activation of Tumor Necrosis Factor by a Spirochetal Lipoprotein

Irina A. Udalova,* Vincent Vidal, Ian G. Scragg, and Dominic Kwiatkowski

Molecular Infectious Disease Group, Institute of Molecular Medicine, The John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom

Received 29 November 1999/Returned for modification 23 February 2000/Accepted 9 June 2000

Variable major lipoprotein (Vmp) is a major tumor necrosis factor (TNF)-inducing component of Borrelia recurrentis, the agent of louse-borne relapsing fever. B. recurrentis Vmp rapidly stimulates nuclear translocation of NF-kappa B and proinflammatory cytokine gene expression in the human monocyte-like cell line MonoMac 6. By overexpressing disabled mutant Ikappa Balpha in MonoMac 6 cells cotransfected with a reporter gene, we provide evidence that NF-kappa B is essential for the transcriptional activation of TNF in this system.


* Corresponding author. Mailing address: Molecular Infectious Disease Group, Institute of Molecular Medicine, The John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom. Phone: 44 1865 222345. Fax: 44 1865 222626. E-mail: iudalova{at}molbiol.ox.ac.uk.


Infection and Immunity, September 2000, p. 5447-5449, Vol. 68, No. 9
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Atkinson, S. H., Rockett, K. A., Morgan, G., Bejon, P. A., Sirugo, G., O'Connell, M. A., Hanchard, N., Kwiatkowski, D. P., Prentice, A. M. (2008). Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children. Blood 112: 4276-4283 [Abstract] [Full Text]  
  • Jove, M., Planavila, A., Sanchez, R. M., Merlos, M., Laguna, J. C., Vazquez-Carrera, M. (2006). Palmitate Induces Tumor Necrosis Factor-{alpha} Expression in C2C12 Skeletal Muscle Cells by a Mechanism Involving Protein Kinase C and Nuclear Factor-{kappa}B Activation. Endocrinology 147: 552-561 [Abstract] [Full Text]  
  • Dryer, R. L., Covey, L. R. (2005). A Novel NF-{kappa}B-Regulated Site within the Human I{gamma}1 Promoter Requires p300 for Optimal Transcriptional Activity. J. Immunol. 175: 4499-4507 [Abstract] [Full Text]